Literature DB >> 28068324

Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis.

E Agarwal1,2, C M Robb1, L M Smith3, M G Brattain1,2, J Wang1, J D Black1, S Chowdhury4.   

Abstract

Survival signaling is critical for the metastatic program of cancer cells. The current study investigated the role of Akt survival proteins in colorectal cancer (CRC) metastasis and explored potential mechanisms of Akt-mediated metastasis regulation. Using an orthotopic implantation model in mice, which uniquely recapitulates the entire multistep process of CRC metastasis, combined with an inducible system of short hairpin RNA-mediated Akt isoform knockdown in human CRC cells, our studies confirm a role of Akt2 in CRC cell dissemination to distant organs in vivo. Akt2 deficiency profoundly inhibited the development of liver lesions in mice, whereas Akt1 had no effect under the experimental conditions used in the study. Array analysis of human metastatic genes identified the scaffolding protein metastasis suppressor 1 (MTSS1) as a novel Akt2-regulated gene. Inducible loss of Akt2 in CRC cells robustly upregulated MTSS1 at the messenger RNA and protein level, and the accumulated protein was functionally active as shown by its ability to engage an MTSS1-Src-cortactin inhibitory axis. MTSS1 expression led to a marked reduction in levels of functional cortacin (pcortactin Y421), an actin nucleation-promoting factor that has a crucial role in cancer cell invasion and metastasis. MTSS1 was also shown to mediate suppressive effects of Akt2 deficiency on CRC cell viability, survival, migration and actin polymerization in vitro. The relevance of these findings to human CRC is supported by analysis of The Cancer Genome Atlas (TCGA) and NCBI GEO data sets, which demonstrated inverse changes in expression of Akt2 and MTSS1 during CRC progression. Taken together, the data identify MTSS1 as a new Akt2-regulated gene, and point to suppression of MTSS1 as a key step in the metastasis-promoting effects of Akt2 in CRC cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28068324      PMCID: PMC5667907          DOI: 10.1038/onc.2016.460

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  72 in total

1.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

Review 2.  The Akt-associated microRNAs.

Authors:  Min Xu; Yin-Yuan Mo
Journal:  Cell Mol Life Sci       Date:  2012-08-31       Impact factor: 9.261

3.  Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.

Authors:  Peng Du; Lin Ye; Fiona Ruge; Yong Yang; Wen G Jiang
Journal:  Anticancer Res       Date:  2011-10       Impact factor: 2.480

4.  MIM and cortactin antagonism regulates ciliogenesis and hedgehog signaling.

Authors:  Marina Bershteyn; Scott X Atwood; Wei-Meng Woo; Mischa Li; Anthony E Oro
Journal:  Dev Cell       Date:  2010-08-17       Impact factor: 12.270

5.  Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines.

Authors:  K Nakatani; D A Thompson; A Barthel; H Sakaue; W Liu; R J Weigel; R A Roth
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

6.  Expression and Significances of MTSS1 in Pancreatic Cancer.

Authors:  Li Zhou; Jian Li; Qian-Qian Shao; Jun-Chao Guo; Zhi-Yong Liang; Wei-Xun Zhou; Tai-Ping Zhang; Lei You; Yu-Pei Zhao
Journal:  Pathol Oncol Res       Date:  2015-07-22       Impact factor: 3.201

7.  Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology.

Authors:  Robert D Loberg; Chris K Neeley; Lashon L Adam-Day; Yaron Fridman; Lauren N St John; Sheri Nixdorf; Paul Jackson; Linda M Kalikin; Kenneth J Pienta
Journal:  Int J Oncol       Date:  2005-06       Impact factor: 5.650

8.  Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.

Authors:  J Wang; W Han; E Zborowska; J Liang; X Wang; J K Willson; L Sun; M G Brattain
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

9.  Activated eosinophils upregulate the metastasis suppressor molecule E-cadherin on prostate tumor cells.

Authors:  P M Furbert-Harris; D Parish-Gause; K A Hunter; T R Vaughn; C Howland; J Okomo-Awich; K Forrest; I Laniyan; A Abdelnaby; O A Oredipe
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2003-11       Impact factor: 1.770

10.  Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.

Authors:  Jian Li; Yuxiang Chen; Xiong Guo; Ling Zhou; Zeming Jia; Yaping Tang; Ling Lin; Weidong Liu; Caiping Ren
Journal:  Tumour Biol       Date:  2016-01-07
View more
  16 in total

1.  Missing-in-metastasis protein downregulates CXCR4 by promoting ubiquitylation and interaction with small Rab GTPases.

Authors:  Lushen Li; Shaneen S Baxter; Ning Gu; Min Ji; Xi Zhan
Journal:  J Cell Sci       Date:  2017-03-06       Impact factor: 5.285

2.  UEG Week 2020 Poster Presentations.

Authors: 
Journal:  United European Gastroenterol J       Date:  2020-10       Impact factor: 4.623

3.  Metastasis suppressor 1 (MTSS1) expression is associated with reduced in-vivo metastasis and enhanced patient survival in lung adenocarcinoma.

Authors:  Matthew D Taylor; Oana Bollt; Soumya C Iyer; Gavin P Robertson
Journal:  Clin Exp Metastasis       Date:  2017-12-07       Impact factor: 5.150

4.  UCHL3 promotes aerobic glycolysis of pancreatic cancer through upregulating LDHA expression.

Authors:  Y Fan; D Hu; D Li; C Ma; Y Tang; Q Tao; L Deng; D Tang
Journal:  Clin Transl Oncol       Date:  2021-02-22       Impact factor: 3.405

5.  Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.

Authors:  Zhenbing Lv; Jinlai Wei; Wenxian You; Rong Wang; Jingkun Shang; Yongfu Xiong; Hua Yang; Xuanhua Yang; Zhongxue Fu
Journal:  J Transl Med       Date:  2017-12-19       Impact factor: 5.531

6.  High miR-31-5p expression promotes colon adenocarcinoma progression by targeting TNS1.

Authors:  Bobin Mi; Qiushi Li; Tong Li; Guohui Liu; Jiayang Sai
Journal:  Aging (Albany NY)       Date:  2020-04-21       Impact factor: 5.682

Review 7.  Contributions of Thyroid Hormone to Cancer Metastasis.

Authors:  Shaker A Mousa; Gennadi V Glinsky; Hung-Yun Lin; Osnat Ashur-Fabian; Aleck Hercbergs; Kelly A Keating; Paul J Davis
Journal:  Biomedicines       Date:  2018-08-22

Review 8.  Cortactin in cancer cell migration and invasion.

Authors:  Miao Yin; Wenqing Ma; Liguo An
Journal:  Oncotarget       Date:  2017-09-19

9.  Identification of candidate genes and long non-coding RNAs associated with the effect of ATP5J in colorectal cancer.

Authors:  Bingjun Bai; Binbin Xie; Zongyou Pan; Lina Shan; Jianpei Zhao; Hongbo Zhu
Journal:  Int J Oncol       Date:  2018-02-22       Impact factor: 5.650

10.  Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/β-catenin signaling pathway in colorectal cancer.

Authors:  Yuandong Xu; Xuejuan Liu; Huizhong Zhang; Ziyuan Zhu; Xianqiu Wu; Xiaobing Wu; Shuling Li; Libing Song; Xuehu Xu
Journal:  Oncol Rep       Date:  2018-07-02       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.